|
gptkb:RET_fusion-positive_cancers
|
secondary RET mutations
|
|
gptkb:EGFR_mutation-positive_NSCLC
|
MET amplification
|
|
gptkb:NTRK_fusion-positive_cancers
|
NTRK kinase domain mutation
|
|
gptkb:EGFR_mutation-positive_NSCLC
|
HER2 amplification
|
|
gptkb:HRAS-mutant_tumors
|
secondary RAS mutations
|
|
gptkb:BRAF_V600E-mutant_colorectal_cancer
|
EGFR pathway activation
|
|
gptkb:EGFR_mutation-positive_NSCLC
|
small cell transformation
|
|
gptkb:NTRK_fusion-positive_cancers
|
bypass signaling pathway activation
|
|
gptkb:HRAS-mutant_tumors
|
upregulation of alternative pathways
|
|
gptkb:RET_fusion-positive_cancers
|
MET amplification
|